A $22 million investment via California State Assembly Bill 2664 is supporting innovation and entrepreneurship at UC San Francisco and across the University of California system.
Ten years after the QB3 Garage incubator launched, the idea has grown an innovation ecosystem and become the catalyst for state legislation that could help turn ideas at UC campuses into job-providing companies.
UCSF announced the establishment of the Quantitative Biosciences Institute (QBI), to drive forward the application of computation, mathematics, and statistics toward a deeper understanding of complex problems in biology.
The inaugural Byers Family Distinguished Professorship has been awarded to Regis Kelly, PhD, in recognition of his visionary leadership at QB3, a thriving center of early-stage entrepreneurship and innovation that has capitalized on the premier health sciences research coming out of UCSF.
Nobel Prize winner Stanley Prusiner is closing in on better treatments for Alzheimer's, Parkinson's and other brain diseases, and an unlikely new partnership will get him there faster.
School of Medicine Dean Sam Hawgood, MBBS, announced the appointment of Joseph DeRisi, PhD, as the new chair of the Department of Biochemistry and Biophysics, on March 3.
Precision Medicine Pillar No. 5: Omics Medicine. Molecular biologist Nevan Krogan's work is not only illuminating how genes and proteins function, it's also shedding light on the underlying biology of disease for each person.
The California Institute for Quantitative Biosciences (QB3) will hold a news conference and media tours to launch the institute’s new bioscience incubator, near the UC San Francisco campus at Mission Bay.
Eleven leading scientists from the California Institute for Quantitative Biosciences (QB3) presented their latest aging research findings and anti-aging strategies at a daylong symposium called “The Science of Staying Younger Longer.”